about
Pim Kinases Promote Migration and Metastatic Growth of Prostate Cancer XenograftsHypoxia-inducible factor-1α induces ErbB4 signaling in the differentiating mammary glandInteraction with ErbB4 promotes hypoxia-inducible factor-1α signaling.Plasminogen Activator Inhibitor-1 Controls Vascular Integrity by Regulating VE-Cadherin TraffickingIsoform-specific monoubiquitination, endocytosis, and degradation of alternatively spliced ErbB4 isoforms.ErbB4 and its isoforms: patentable drug targets?Analyses in zebrafish embryos reveal that nanotoxicity profiles are dependent on surface-functionalization controlled penetrance of biological membranes.FiloQuant reveals increased filopodia density during breast cancer progression.Lymphatic endothelium stimulates melanoma metastasis and invasion via MMP14-dependent Notch3 and β1-integrin activation.Interaction between marrow-derived human mesenchymal stem cells and peripheral blood mononuclear cells in endothelial cell differentiation.CYT-1 isoform of ErbB4 is an independent prognostic factor in serous ovarian cancer and selectively promotes ovarian cancer cell growth in vitro.Junction-based lamellipodia drive endothelial cell rearrangements in vivo via a VE-cadherin/F-actin based oscillatory ratchet mechanismReceptor tyrosine kinase profiling of ischemic heart identifies ROR1 as a potential therapeutic targetJunction-based lamellipodia drive endothelial cell rearrangements in vivo via a VE-cadherin-F-actin based oscillatory cell-cell interactionSORLA regulates endosomal trafficking and oncogenic fitness of HER2ErbB4 tyrosine kinase inhibition impairs neuromuscular development in zebrafish embryos.Differential nuclear localization and kinase activity of alternative ErbB4 intracellular domainsIntra- and extracellular signaling by endothelial neuregulin-1GGA2 and RAB13 promote activity-dependent β1-integrin recyclingGenetic and functional implications of an exonic TRIM55 variant in heart failureAn unbiased in vitro screen for activating epidermal growth factor receptor mutations
P50
Q27304359-E353CB96-30DC-4E45-88FC-E3A3E4A4E773Q34070488-9B25E895-2289-48D6-AF88-6A363399F053Q35879939-FC1A2248-FC4D-428E-B486-CC0F33B006C1Q35880793-4160EBC4-4B22-4992-8968-EABBEB70D689Q36670188-DFBD2169-206C-4F6E-853C-E06D55DA16D9Q37347980-75D1264C-A163-42F7-BAC7-4A9222D88B44Q38615276-40DAD942-65D6-40B1-95D8-1540499A37F4Q38648007-EB24315E-B97A-4385-BB17-57DFDDC1425BQ52715474-67265452-FE3D-4BBF-8562-68F3E106B0CBQ54337702-97C9DBE6-8441-4E53-B31C-67527096F8EAQ54457600-AA02FA17-8672-4BAC-9008-E3C521DE586CQ57232997-5B2F527E-F005-46A3-B003-ED6E4D7C1EC5Q57807470-738B5AF2-8A1E-4EAD-B561-050F9D7701C0Q58782261-160F1C7A-2470-4D25-ACCB-D4DA030EB31BQ64289807-53471851-2BE5-4609-8F4C-8C14F45AE1CEQ64997701-F6351ED4-A203-405F-B2F1-B9E880423529Q80282010-76DCAD7B-B86F-45D9-82B8-5FD041419796Q80326360-EE12E2EE-ED81-4023-99E8-F23323A681FDQ91929839-E8AB6751-AA66-48F4-A75D-FB1B9C33212BQ92184951-9E58A0B0-2E98-4BD4-AAD1-246855617A0AQ92884879-635282E5-B273-47B5-8650-4BA7B7D17E7B
P50
description
researcher, ORCID id # 0000-0001-5926-2396
@en
wetenschapper
@nl
name
Ilkka Paatero
@ast
Ilkka Paatero
@en
Ilkka Paatero
@es
Ilkka Paatero
@nl
type
label
Ilkka Paatero
@ast
Ilkka Paatero
@en
Ilkka Paatero
@es
Ilkka Paatero
@nl
prefLabel
Ilkka Paatero
@ast
Ilkka Paatero
@en
Ilkka Paatero
@es
Ilkka Paatero
@nl
P106
P31
P496
0000-0001-5926-2396